London, March 4, 2026, 09:43 (GMT) — Regular session
- Schroders traded sideways at 585p early on, still hovering roughly 27p under Nuveen’s 612p offer.
- BlackRock now holds a 6.16% long stake in Schroders. Societe Generale reported a long position of 2.19%, alongside 1.08% shorts.
- Investors are eyeing the scheme document, expected this month, and upcoming April shareholder meetings that will outline the deal’s timetable.
Schroders didn’t move much in early London trade Wednesday, with new takeover-code filings keeping the spotlight on Nuveen’s all-cash offer and what comes next before a shareholder vote.
The stock’s turned into a deal spread play. Traders now have to juggle timing, regulatory risks, and the chance a sizable group of holders balks at the offer—especially with the process likely dragging on for months.
Schroders held steady at 585.0 pence as of 0925 GMT, showing no move from earlier levels. The stock opened at 585.5p and, to this point, hasn’t strayed outside a narrow 585.0p to 586.0p band, share price data show.
According to the offer document, Nuveen’s Bidco is putting up as much as 612 pence per share—split between 590 pence in cash and, if declared or paid before completion, as much as 22 pence in so-called “permitted dividends.”
The headline offer is about 27 pence higher than Wednesday morning’s share price, a premium just over 4%. That gap points to the lengthy timeline ahead, and the uncertainty hanging over whether the deal will actually close.
The Rule 2.7 announcement pegs March for the scheme document and proxy form distribution, with the court meeting and general meeting scheduled for April 2026. The deal, according to the same release, is still tracking for completion sometime in the fourth quarter of 2026.
BlackRock, Inc reported a total long position of 6.16% in Schroders as of March 2, according to a Form 8.3 disclosure dated March 3. That figure, which factors in cash-settled derivatives, landed alongside disclosed short positions of 0.03%.
Societe Generale updated its Form 8.3, revealing it owned 2.19% of Schroders stock as of Feb. 27, and had short bets — derivatives included — totaling 1.08%.
Schroders executive Johanna Kyrklund reported holding 10,742 shares and disclosed nil-cost options tied to incentive plans, according to a Form 8 (DD) filing.
Last month, when the takeover was announced, Schroders’ CEO Richard Oldfield called Nuveen “a partner that shares our values.”
This climate weighs on competitors as well. Reuters previously noted that Schroders’ sale highlighted how mid-sized European active managers face mounting pressure—fee compression and the surge of passive funds are forcing them to scale up or exit.
The road ahead isn’t straightforward. According to the announcement, the scheme hinges on hitting shareholder approval targets at meetings and clearing regulatory hurdles. The company flagged that the process could stretch all the way into Q4 2026, leaving plenty of time for market forces, politics, or investor sentiment to move. Should the deal fall through, shares could tumble back toward pre-offer prices; Schroders ended at 456p right before the news broke.
Traders now turn their focus to March, eyeing the scheme document’s release, with dates for the April court and general meetings set to mark the key points ahead of the shareholder vote.
